XML 58 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Series E Preferred Stock
Series E Preferred Stock
Preferred Stock
Series E Preferred Stock
Additional Paid-in Capital
Beginning Balance at Dec. 31, 2017 $ (45,615) $ 0 $ 59 $ 519,531 $ (569,759) $ 4,604 $ (50)      
Beginning Balance, shares (in shares) at Dec. 31, 2017   0 58,645              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net loss (8,143)       (8,058)   (85)      
Foreign currency translation adjustment (9,481)         (9,481)        
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 2,408   $ 3 2,405            
Exercise of stock options, vesting of restricted stock units and stock issued under ESPP (in shares)     2,645              
Taxes withheld on net settled vesting of restricted stock units (656)     (656)            
Issuance of common stock 20,086   $ 12 20,074            
Issuance of common stock (in shares)     12,690              
Share-based compensation 4,876     4,876            
Share-based compensation (in shares)     0              
Ending Balance at Dec. 31, 2018 (36,525) $ 0 $ 74 546,230 (577,817) (4,877) (135)      
Ending Balance, shares (in shares) at Dec. 31, 2018   0 73,980              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net loss (40,110)       (40,125)   15      
Foreign currency translation adjustment 998         998        
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 3,265   $ 2 3,263            
Exercise of stock options, vesting of restricted stock units and stock issued under ESPP (in shares)     2,254              
Taxes withheld on net settled vesting of restricted stock units (1,269)     (1,269)            
Issuance of common stock 1,439     1,439       $ 10,000   $ 10,000
Issuance of common stock (in shares)     263           10  
Exercise of warrants     5,477              
Exercise of warrants 17,542   $ 6 17,536            
Share-based compensation 7,302     7,302            
Series E preferred stock dividends 0     361 (361)          
Ending Balance at Dec. 31, 2019 $ (37,358) $ 0 $ 82 $ 584,862 $ (618,303) $ (3,879) $ (120)      
Ending Balance, shares (in shares) at Dec. 31, 2019   10 81,974